Search & Analyze
Popular Searches
Avience Biomedicals Ltd.
Healthcare₹251.20
CMP₹251.20
Mkt Cap₹138 Cr
P/E15.74
P/B5.69
ROE49.90%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
15.74
P/B Ratio
5.69
EV/EBITDA
10.18
Price/Sales
2.62
Dividend Yield (%)
0.00
EPS (TTM ₹)
15.96
Book Value (₹)
44.18
ROE (%)
49.90
ROCE (%)
34.16
ROA (%)
15.90
EBITDA Margin (%)
25.31
Net Profit Margin (%)
15.99
Debt/Equity
0.97
Current Ratio
1.58
Interest Coverage
7.45
Asset Turnover
0.99
Working Capital/Sales
3.31
Core EBITDA Growth (%)
169.91
P&L
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Gross Sales | 2396.4 | 4523.6 |
| Net Sales | 2396.4 | 4523.6 |
| Total Income | 2437.26 | 4596.75 |
| Total Expenditure | 1985.99 | 3378.8 |
| Operating Profit | 451.27 | 1217.95 |
| Depreciation | 61.68 | 85.93 |
| Exceptional Items | — | — |
| Profit Before Tax | 295.86 | 980.07 |
| Tax | 80.7 | 256.89 |
| Profit After Tax (PAT) | 215.16 | 723.18 |
| EPS (₹) | 6.55 | 19.06 |
| Dividend Payout % | — | — |
Balance Sheet
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Share Capital | 328.45 | 403.13 |
| Reserves | 294.31 | 1874.59 |
| Shareholders Funds | 622.76 | 2277.72 |
| Total Debt | 1513.06 | 2215.81 |
| Total Liabilities | 3454.27 | 5645.03 |
| Total Assets | 3454.27 | 5645.03 |
| Book Value / Share | 18.9606 | 56.5009 |
| Assets | 3454.27 | 5645.03 |
Cash Flows
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Operating Activities | 98.5 | 360.63 |
| Investing Activities | -402.77 | -880.59 |
| Financing Activities | 296.71 | 925.37 |
| Net Cash Flow | -7.5600000000000005 | 405.41 |
AVIENCE
₹251.20
+0%